SCA11
MCID: SPN305
MIFTS: 45
|
Spinocerebellar Ataxia 11 (SCA11)
Categories:
Ear diseases, Eye diseases, Fetal diseases, Genetic diseases, Liver diseases, Mental diseases, Metabolic diseases, Muscle diseases, Neuronal diseases, Rare diseases, Skin diseases
|
|
MalaCards integrated aliases for Spinocerebellar Ataxia 11:
Characteristics:Orphanet epidemiological data:58
spinocerebellar ataxia type 11
Inheritance: Autosomal dominant; Prevalence: <1/1000000 (Worldwide); Age of onset: Adolescent,Adult,Childhood,Elderly; Age of death: elderly; HPO:31
spinocerebellar ataxia 11:
Inheritance autosomal dominant inheritance Onset and clinical course adult onset GeneReviews:24
Penetrance The ttbk2 pathogenic variants in the six families described to date appear to be fully penetrant, although a number of at-risk relatives are younger than the typical age of onset. to date, no non-penetrant pathogenic variants have been identified in older individuals.
Classifications:
MalaCards categories:
Global: Genetic diseases Rare diseases Metabolic diseases Fetal diseases Anatomical: Neuronal diseases Eye diseases Liver diseases Skin diseases Ear diseases Muscle diseases Mental diseases
ICD10:
33
Orphanet: 58
![]() |
NIH Rare Diseases :
52
Spinocerebellar ataxia type 11 (SCA11) is characterized by progressive cerebellar ataxia (difficulty walking and balance) and abnormal eye signs (jerky pursuit, horizontal and vertical movements (nystagmus ), pyramidal features (increased muscular tonus, increased reflexes and an abnormal reflex known as Babinski sign and inability to make to perform fine movements), peripheral neuropathy with numbness, weakness or pain in the feet or hands or other places of the body and dystonia . It is a very rare disease and very few patients have been reported to date. Age of onset ranges from the early teens to the mid 20s and life span is normal. Diagnosis is based on signs and symptoms and is confirmed by genetic testing finding a change (mutation ) in the TTBK2 gene . It is inherited in an autosomal dominant manner. Treatment may include speech and language therapy for talking and swallowing problems, occupational therapy, including home adaptations, physiotherapy and use of assistive walking devices and ankle-foot orthotics (AFOs) for those with neuropathy.
MalaCards based summary : Spinocerebellar Ataxia 11, also known as spinocerebellar ataxia type 11, is related to spinocerebellar ataxia, autosomal recessive 11 and spinocerebellar ataxia 1. An important gene associated with Spinocerebellar Ataxia 11 is TTBK2 (Tau Tubulin Kinase 2), and among its related pathways/superpathways are Regulation of PLK1 Activity at G2/M Transition and Organelle biogenesis and maintenance. Affiliated tissues include eye, cerebellum and spinal cord, and related phenotypes are dysphagia and dysarthria Disease Ontology : 12 An autosomal dominant cerebellar ataxia that is characterized by ataxia, nystagmus, pyramidal abonormalities and peripheral neuropathy, has material basis in mutation in the TTBK2 gene. UniProtKB/Swiss-Prot : 73 Spinocerebellar ataxia 11: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA11 is an autosomal dominant cerebellar ataxia (ADCA). It is a relatively benign, late- onset, slowly progressive neurologic disorder.
GeneReviews:
NBK1757
|
Human phenotypes related to Spinocerebellar Ataxia 11:58 31 (show all 14)
|
|
MalaCards organs/tissues related to Spinocerebellar Ataxia 11:40
Eye,
Cerebellum,
Spinal Cord,
Testes
|
Articles related to Spinocerebellar Ataxia 11:(show all 28)
|
ClinVar genetic disease variations for Spinocerebellar Ataxia 11:6 (show top 50) (show all 84)
|
Search
GEO
for disease gene expression data for Spinocerebellar Ataxia 11.
|
Cellular components related to Spinocerebellar Ataxia 11 according to GeneCards Suite gene sharing:
Biological processes related to Spinocerebellar Ataxia 11 according to GeneCards Suite gene sharing:
Molecular functions related to Spinocerebellar Ataxia 11 according to GeneCards Suite gene sharing:
|
|